{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:05:58Z","timestamp":1771049158819,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.pcl.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T04:13:06Z","timestamp":1269144786000},"page":"47-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors"],"prefix":"10.1016","volume":"57","author":[{"given":"David","family":"Barrett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan A.","family":"Grupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9579","key":"10.1016\/j.pcl.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pcl.2010.01.001_bib2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1200\/JCO.2002.06.060","article-title":"Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study","volume":"20","author":"Kletzel","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00043426-199707000-00008","article-title":"High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors","volume":"19","author":"Kreissman","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V93.3.761","article-title":"Problems in Hodgkin's disease management","volume":"93","author":"Aisenberg","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2003-39372","article-title":"Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook","volume":"215","author":"Dorffel","year":"2003","journal-title":"Klin Padiatr"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib6","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","article-title":"High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group","volume":"17","author":"Schellong","year":"1999","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1442-200X.1991.tb02594.x","article-title":"Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983\u20131987","volume":"33","author":"Balwierz","year":"1991","journal-title":"Acta Paediatr Jpn"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2010.01.001_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/5.suppl_2.S113","article-title":"Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German\/Austrian Pediatric Study Group","volume":"5","author":"Schellong","year":"1994","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002770050014","article-title":"Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients","volume":"79","author":"Anselmo","year":"2000","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib10","first-page":"467","article-title":"Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial","volume":"20","author":"Ferme","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-199704040-00010","article-title":"Recent advances in the treatment of Hodgkin's disease","volume":"4","author":"Yuen","year":"1997","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib12","first-page":"99","article-title":"Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP\/ABVD protocol","volume":"8","author":"Carella","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1200\/JCO.2003.11.103","article-title":"High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy","volume":"21","author":"Federico","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8852","key":"10.1016\/j.pcl.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"issue":"9323","key":"10.1016\/j.pcl.2010.01.001_bib15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1200\/JCO.1993.11.11.2243","article-title":"Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry","volume":"11","author":"Williams","year":"1993","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00043426-200411000-00010","article-title":"Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease","volume":"26","author":"Stoneham","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.1999.17.3.825","article-title":"Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents","volume":"17","author":"Baker","year":"1999","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.pcl.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2005.01.701","article-title":"Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma","volume":"23","author":"Claviez","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.bmt.1702094","article-title":"Autologous stem cell transplantation for advanced Hodgkin's disease in children. Spanish group for BMT in children (GETMON), Spain","volume":"25","author":"Verdeguer","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bbmt.2007.12.496","article-title":"Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement","volume":"14","author":"Anderlini","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.pcl.2010.01.001_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bmt.1705977","article-title":"Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation","volume":"41","author":"Thomson","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib23","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1993.11.12.2342","article-title":"Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1200\/JCO.2007.13.2415","article-title":"Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"26","author":"Sureda","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbmt.2005.09.009","article-title":"Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: results of a Spanish prospective cooperative protocol","volume":"12","author":"Alvarez","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9475","key":"10.1016\/j.pcl.2010.01.001_bib26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0140-6736(05)66659-7","article-title":"Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation","volume":"365","author":"Peggs","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.pcl.2010.01.001_bib27","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.pcl.2010.01.001_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin's lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib29","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","article-title":"Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"97","author":"Seidemann","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.pcl.2010.01.001_bib30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","volume":"19","author":"Kobrinsky","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pcl.2010.01.001_bib31","article-title":"Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents","author":"Gross","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2010.01.001_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1399-3046.1999.00053.x","article-title":"High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results","volume":"3","author":"Chen","year":"1999","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737140.8.4.617","article-title":"Ewing sarcoma: prognostic criteria, outcomes and future treatment","volume":"8","author":"Leavey","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/pbc.21618","article-title":"Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children's Oncology Group","volume":"51","author":"Leavey","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.pcl.2010.01.001_bib35","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/pbc.21233","article-title":"Treatment of metastatic Ewing sarcoma\/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy\u2013a report from the Children's Oncology Group","volume":"49","author":"Miser","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib36","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2001.19.11.2812","article-title":"High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis","volume":"19","author":"Meyers","year":"2001","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.pcl.2010.01.001_bib37","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2003.12.039","article-title":"High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation","volume":"21","author":"Burdach","year":"2003","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1023\/A:1026539908115","volume":"11","author":"Burdach","year":"2000","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.pcl.2010.01.001_bib39","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2006.05.7059","article-title":"Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers de l'Enfant","volume":"24","author":"Oberlin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/annonc\/mdg457","article-title":"Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997","volume":"14","author":"Bacci","year":"2003","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.pcl.2010.01.001_bib41","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2005.05.105","article-title":"Survival after recurrence of Ewing's sarcoma family of tumors","volume":"23","author":"Barker","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008480-199702000-00013","article-title":"Autologous stem cell transplantation for solid tumors in children","volume":"9","author":"Ladenstein","year":"1997","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The Third Intergroup Rhabdomyosarcoma Study","volume":"13","author":"Crist","year":"1995","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.pcl.2010.01.001_bib44","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2005.01.9497","article-title":"Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"24","author":"Lager","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib45","first-page":"91","article-title":"Melphalan: a potential new agent in the treatment of childhood rhabdomyosarcoma","volume":"69","author":"Houghton","year":"1985","journal-title":"Cancer Treat Rep"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1983.1.6.359","article-title":"Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer","volume":"1","author":"Lazarus","year":"1983","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1700628","article-title":"Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German\/Austrian Pediatric Bone Marrow Transplantation Group","volume":"19","author":"Koscielniak","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/bjc.1991.313","article-title":"Rapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomas","volume":"64","author":"Pinkerton","year":"1991","journal-title":"Br J Cancer"},{"issue":"34","key":"10.1016\/j.pcl.2010.01.001_bib49","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1200\/JCO.2004.00.2931","article-title":"Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy","volume":"23","author":"Bagatell","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib50","first-page":"791","article-title":"New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status","volume":"26","author":"Simon","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"13","key":"10.1016\/j.pcl.2010.01.001_bib51","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1200\/JCO.2000.18.13.2567","article-title":"Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma","volume":"18","author":"Grupp","year":"2000","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.pcl.2010.01.001_bib52","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib53","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.1991.9.6.1050","article-title":"Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma","volume":"9","author":"Cheung","year":"1991","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.pcl.2010.01.001_bib54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","article-title":"Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial","volume":"6","author":"Berthold","year":"2005","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.pcl.2010.01.001_bib55","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1200\/JCO.2006.05.6986","article-title":"High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update","volume":"24","author":"George","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1200\/JCO.1991.9.6.962","article-title":"Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases","volume":"9","author":"Dini","year":"1991","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.pcl.2010.01.001_bib57","first-page":"42","article-title":"Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group","volume":"4","author":"Dini","year":"1989","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.1991.9.2.274","article-title":"Myeloablative combination chemotherapy without total body irradiation for neuroblastoma","volume":"9","author":"Kushner","year":"1991","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.pcl.2010.01.001_bib59","first-page":"S21","article-title":"Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma","volume":"18","author":"Matthay","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib60","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0959-8049(95)00015-B","article-title":"Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results","volume":"31","author":"Matthay","year":"1995","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.1991.9.1.152","article-title":"High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study","volume":"9","author":"Pole","year":"1991","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib62","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0959-8049(97)00324-9","article-title":"1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party","volume":"33","author":"Philip","year":"1997","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib63","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/1096-911X(20001201)35:6<696::AID-MPO46>3.0.CO;2-0","article-title":"Rapid-sequence tandem transplant for children with high-risk neuroblastoma","volume":"35","author":"Grupp","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/bjc.1993.21","article-title":"Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study","volume":"67","author":"Philip","year":"1993","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.pcl.2010.01.001_bib65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/pbc.20769","article-title":"Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day","volume":"46","author":"Grupp","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V84.2.380.380","article-title":"Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells","volume":"84","author":"Rill","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-5728(99)00030-2","article-title":"Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level","volume":"96","author":"Hafer","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.pcl.2010.01.001_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-5728(97)00088-X","article-title":"Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: consequences for autologous bone marrow and peripheral blood stem cell transplantation","volume":"78","author":"Voigt","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib69","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1096-911X(20001201)35:6<677::AID-MPO42>3.0.CO;2-H","article-title":"CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies","volume":"35","author":"Donovan","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-911X(200007)35:1<1::AID-MPO1>3.0.CO;2-C","article-title":"Long-term results of CD34(+) cell transplantation in children with neuroblastoma","volume":"35","author":"Kanold","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib71","first-page":"5882","article-title":"Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads","volume":"46","author":"Reynolds","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2010.01.001_bib72","first-page":"285","article-title":"Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads","volume":"211","author":"Seeger","year":"1986","journal-title":"Prog Clin Biol Res"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib73","first-page":"155","article-title":"Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent","volume":"20","author":"Wieland","year":"1979","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.pcl.2010.01.001_bib74","first-page":"736","article-title":"Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases","volume":"26","author":"Geatti","year":"1985","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib75","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1096-911X(199906)32:6<427::AID-MPO6>3.0.CO;2-T","article-title":"131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status","volume":"32","author":"Tepmongkol","year":"1999","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.1998.16.1.229","article-title":"Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma","volume":"16","author":"Matthay","year":"1998","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib77","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2004.08.058","article-title":"Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma","volume":"22","author":"DuBois","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1096-911X(199806)30:6<339::AID-MPO7>3.0.CO;2-F","article-title":"Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma","volume":"30","author":"Goldberg","year":"1998","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib79","first-page":"228","article-title":"[131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma","volume":"35","author":"Corbett","year":"1991","journal-title":"J Nucl Biol Med"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0959-8049(94)E0036-4","article-title":"Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma","volume":"31","author":"Gaze","year":"1995","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.pcl.2010.01.001_bib81","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0959-8049(98)00130-0","article-title":"Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study","volume":"34","author":"Klingebiel","year":"1998","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2010.01.001_bib82","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.2005.03.6400","article-title":"Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a New Approaches to Neuroblastoma Therapy Consortium Study","volume":"24","author":"Matthay","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib83","first-page":"3","article-title":"The role of marrow autografting in neuroblastoma","volume":"4","author":"Graham-Pole","year":"1989","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib84","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.1994.12.11.2382","article-title":"Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Children's Cancer Group","volume":"12","author":"Matthay","year":"1994","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.pcl.2010.01.001_bib85","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.1999.17.7.2044","article-title":"Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect","volume":"17","author":"Childs","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bmt.1703609","article-title":"Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients","volume":"30","author":"Bay","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib87","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/TP.0b013e3181949c16","article-title":"Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation","volume":"87","author":"Uhlin","year":"2009","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib88","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.bmt.1703287","article-title":"A graft-versus-colonic cancer effect of allogeneic stem cell transplantation","volume":"28","author":"Zetterquist","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.pcl.2010.01.001_bib89","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","article-title":"The allogeneic graft-versus-cancer effect","volume":"147","author":"Ringden","year":"2009","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib90","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1158\/0008-5472.CAN-08-2517","article-title":"Donor CD4 T cells are critical in allogeneic stem cell transplantation against murine solid tumor","volume":"69","author":"Kamiryo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2010.01.001_bib91","doi-asserted-by":"crossref","first-page":"879765","DOI":"10.1155\/2009\/879765","article-title":"Full response of a localized renal tumour after reduced-intensity conditioned hematopoietic stem cell transplantation","volume":"2009","author":"Gac","year":"2009","journal-title":"Case Report Med"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1704070","article-title":"Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation","volume":"32","author":"Inoue","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.seminoncol.2003.11.002","article-title":"Allogeneic stem cell transplantation as immunotherapy for nonhematological cancers","volume":"31","author":"Srinivasan","year":"2004","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2010.01.001_bib94","first-page":"37","article-title":"Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation","volume":"14","author":"Ladenstein","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.pcl.2010.01.001_bib95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0889-8588(05)70255-0","article-title":"Monoclonal antibody-based therapy of neuroblastoma","volume":"15","author":"Cheung","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"issue":"17","key":"10.1016\/j.pcl.2010.01.001_bib96","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1200\/JCO.2004.08.143","article-title":"Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma","volume":"22","author":"Simon","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib97","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bmt.1704402","article-title":"An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma","volume":"33","author":"Powell","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pcl.2010.01.001_bib98","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","article-title":"Lymphocyte depletion during treatment with intensive chemotherapy for cancer","volume":"84","author":"Mackall","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2010.01.001_bib99","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V96.2.754.014k39_754_762","article-title":"Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults","volume":"96","author":"Mackall","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2010.01.001_bib100","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1172\/JCI32446","article-title":"Adoptive T cell therapy for cancer in the clinic","volume":"117","author":"June","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pcl.2010.01.001_bib101","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1172\/JCI31446","article-title":"Principles of adoptive T cell cancer therapy","volume":"117","author":"June","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcl.2010.01.001_bib102","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/intimm\/7.6.891","article-title":"CD28 ligands CD80 (B7-1) and CD86 (B&-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro","volume":"7","author":"Levine","year":"1995","journal-title":"Int Immunol"},{"key":"10.1016\/j.pcl.2010.01.001_bib103","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0041-1345(97)00216-9","article-title":"Ex vivo replicative potential of adult human peripheral blood CD4+ T cells","volume":"29","author":"Levine","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.pcl.2010.01.001_bib104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/scd.1.1998.7.437","article-title":"Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3\/CD28 costimulation","volume":"7","author":"Levine","year":"1998","journal-title":"J Hematother"},{"key":"10.1016\/j.pcl.2010.01.001_bib105","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1182\/blood-2003-01-0095","article-title":"Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed\/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation","volume":"102","author":"Laport","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib106","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/nm1310","article-title":"Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer","volume":"11","author":"Rapoport","year":"2005","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.pcl.2010.01.001_bib107","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.onc.1203358","article-title":"High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma","volume":"19","author":"Islam","year":"2000","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.pcl.2010.01.001_bib108","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/jpsu.2001.28839","article-title":"The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma","volume":"36","author":"Azuhata","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"36","key":"10.1016\/j.pcl.2010.01.001_bib109","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1200\/JCO.2005.05.3314","article-title":"Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma","volume":"24","author":"Coughlin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pcl.2010.01.001_bib111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.1457","article-title":"Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes","volume":"94","author":"Rossig","year":"2001","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2010.01.001_bib112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.mt.6300104","article-title":"Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma","volume":"15","author":"Park","year":"2007","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.pcl.2010.01.001_bib113","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.pcl.2010.01.001_bib114","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bmt.1705809","article-title":"Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation","volume":"40","author":"Trahair","year":"2007","journal-title":"Bone Marrow Transplant"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395510000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395510000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:19:47Z","timestamp":1758475187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395510000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0031395510000027"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2010.01.001","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2010.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}